Neoadjuvant dual checkpoint inhibition followed by immune-chemoradiation in patients with resectable gastric adenocarcinoma

被引：0
|
作者：
Pabon, Cindy M.
Xiao, Lianchun
Badgwell, Brian D.
Mansfield, Paul F.
Ikoma, Naruhiko
Sewastjanow-Silva, Matheus
Lee, Jeffrey H.
Bhutani, Manoop S.
Weston, Brian
Coronel, Emmanuel
Smith, Grace L.
Holliday, Emma
Tian, Jessie
Das, Prajnan
Minsky, Bruce D.
Waters, Rebecca E.
Estrella, Jeannelyn
Li, Jenny Jing
Ajani, Jaffer A.
Murphy, Mariela A. Blum
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Gastroenterol Hepatol & Nutr, Houston, TX USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Gastrointestinal Radiat Oncol, Houston, TX USA
[4] Univ Texas MD Anderson Canc Ctr, Div Canc Med, Dept Gastrointestinal Med Oncol, Houston, TX USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4067
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Neoadjuvant Immune Checkpoint Inhibition in Resectable Lung Cancer
    Walles, Thorsten
    Luecke, Eva
    Ganzert, Christine
    Hass, Peter
    Kreissl, Michael
    Haybaeck, Johannes
    Schreiber, Jens
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 : 113 - 113
  • [2] Longitudinal immune monitoring of patients with resectable esophageal adenocarcinoma treated with Neoadjuvant PD-L1 checkpoint inhibition
    van den Ende, Tom
    Ezdoglian, Aiarpi
    Baas, Lisanne M. M.
    Bakker, Joyce
    Lougheed, Sinead M.
    Harrasser, Micaela
    Waasdorp, Cynthia
    Henegouwen, Mark I. van Berge I.
    Hulshof, Maarten C. C. M.
    Mohammad, Nadia Haj
    van Hillegersberg, Richard
    Mook, Stella
    van der Laken, Conny J. J.
    van Grieken, Nicole C. T.
    Derks, Sarah
    Bijlsma, Maarten F. F.
    van Laarhoven, Hanneke W. M.
    de Gruijl, Tanja D. D.
    ONCOIMMUNOLOGY, 2023, 12 (01):
  • [3] Management of Borderline Resectable Pancreatic Adenocarcinoma With Neoadjuvant GTX Chemotherapy Followed by Combined Chemoradiation
    Horowitz, D. P.
    Ebiana, V.
    Gidea-Addeo, D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S192 - S193
  • [4] Prognostic significance of immune checkpoint molecule expression in resectable gastric adenocarcinoma
    Croitoru, V. M.
    Filippi, A.
    Cazacu, I. M.
    Kitahara, S.
    Matsui, A.
    Lauwers, G.
    Sorop, A.
    Necula, L. G.
    Matei, L.
    Pechianu, C.
    Croitoru, A. E.
    Herlea, V.
    Saftoiu, A.
    Chivu-Economescu, M.
    Dima, S.
    Duda, D. G.
    Popescu, I.
    ANNALS OF ONCOLOGY, 2021, 32 : S1357 - S1357
  • [5] Neoadjuvant Chemoradiation Therapy in Borderline Resectable Pancreatic Adenocarcinoma
    Shafi, S.
    Kaubisch, A.
    PANCREAS, 2015, 44 (08) : 1413 - 1413
  • [6] Neoadjuvant chemoradiation for potentially resectable gastric cancer.
    Barfield, Michael E.
    Untch, Brian R.
    Arcury, Justin T.
    Czito, Brian G.
    Willett, Christopher
    Pappas, Theodore N.
    White, Rebekah Ruth
    Tyler, Douglas S.
    Blazer, Dan G.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [7] Great Debate: Chemoradiation Should be Added to Chemotherapy as a Neoadjuvant Treatment Strategy for Resectable Gastric Adenocarcinoma
    Daniel, Sara K.
    Badgwell, Brian D.
    Mckinley, Sophia K.
    Strong, Vivian E.
    Poultsides, George A.
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (01) : 405 - 412
  • [8] Great Debate: Chemoradiation Should be Added to Chemotherapy as a Neoadjuvant Treatment Strategy for Resectable Gastric Adenocarcinoma
    Sara K. Daniel
    Brian D. Badgwell
    Sophia K. McKinley
    Vivian E. Strong
    George A. Poultsides
    Annals of Surgical Oncology, 2024, 31 : 405 - 412
  • [9] Feasibility of neoadjuvant S-1 and oxaliplatin followed by surgery for resectable advanced gastric adenocarcinoma
    Honma, Yoshitaka
    Yamada, Yasuhide
    Terazawa, Tetsuji
    Takashima, Atsuo
    Iwasa, Satoru
    Kato, Ken
    Hamaguchi, Tetsuya
    Shimada, Yasuhiro
    Ohashi, Masaki
    Morita, Shinji
    Fukagawa, Takeo
    Machida, Nozomu
    Katai, Hitoshi
    SURGERY TODAY, 2016, 46 (09) : 1076 - 1082
  • [10] Outcomes of Neoadjuvant Chemoradiation With and Without Systemic Chemotherapy in Resectable and Borderline Resectable Pancreatic Adenocarcinoma
    Trinh, Katherine, V
    Fischer, Dawn A.
    Gardner, Timothy B.
    Smith, Kerrington D.
    FRONTIERS IN ONCOLOGY, 2020, 10
12345